Explore HIBS ETF price, technical analysis, forecast, and ratings. Get insights on Direxion’s 3X inverse high beta ETF performance and if HIBS ETF is a buy now.
Introduction
HIBS ETF tracks the inverse performance of high beta S&P 500 stocks, amplified by -3X leverage daily.
Investors watch HIBS ETF closely amid volatile markets in March 2026.
President Trump’s pro-growth policies boost equities, hurting this bearish fund.
Latest ETF Price & Trend
As of last market close on March 3, 2026, HIBS ETF price stands at $4.50.
It gained from $4.19 the prior day, up about 7%.
Five-day trend shows volatility with +6.1% recent lift versus S&P 500’s dip.
One-month performance reflects -9.14% drop since late February.
Three-month gain hits +18.42%, but six-month falls -2.77%.
Year-to-date, HIBS ETF trends -2.36% lower.
52-week range spans $14.71 low to $41.69 high.
Overall direction leans bearish long-term as bull markets pressure inverse funds.
This signals caution for short-term traders seeking downside bets.
Technical Analysis
Support levels sit near $4.19 recent lows, where buyers may step in.
Resistance looms at $4.65 prior highs, capping upside moves.
RSI reading hovers neutral around 50, neither overbought nor oversold.
MACD shows bearish crossover, hinting at momentum fade.
50-day moving average at $5.20 exceeds price, signaling short-term weakness.
200-day average near $10 confirms downtrend persistence.
No golden cross; death cross lingers from prior months.
Trading volume surged to 14.9 million shares, above average, showing interest.
These indicators matter as they flag entry/exit points for leveraged plays.
Analyst Ratings & Price Targets
Few analysts cover HIBS ETF due to its tactical nature.
AI models like Danelfin rate it Hold with neutral score.
Average price target sits at $5.20, high $6.00, low $3.50.
No recent upgrades; sentiment stays cautious post-2025 volatility.
Wall Street views favor S&P 500 bulls over inverse bets.
This mixed outlook means investors should weigh leverage risks carefully.
Insider Activity
Direxion manages HIBS ETF; no traditional insiders apply.
Fund flows show net outflows in bullish tape, signaling low conviction.
No large transactions reported in recent SEC filings.
Management holds steady without buying or selling signals.
Stable activity implies neutral confidence in bear ETF strategy.
Valuation Analysis
Leveraged ETFs like HIBS ETF lack P/E ratios.
Instead, focus on decay from daily resets and expense ratio at 1.07%.
Net assets under management hover near $10 million.
No revenue growth metric; performance ties to S&P high beta inverse.
Free cash flow irrelevant; debt-free structure as ETF.
Compare to peers: HIBS underperforms standard inverse like SPXS.
HIBS ETF appears fairly valued for tactical shorts, not long holds.
Recent Earnings & Catalysts
ETFs report no quarterly earnings.
Performance driven by S&P 500 high beta index daily moves.
Recent catalyst: S&P rally post-inauguration beat expectations.
No partnerships; Direxion launched no new products tied to HIBS.
Guidance absent; volatility from Fed rate cuts impacts beta stocks.
Strong equity markets crushed HIBS ETF returns year-to-date.
Bullish Case
HIBS ETF shines in market downturns via -3X leverage.
Rising short interest in high beta names could boost demand.
Economic slowdown fears from 2026 inflation may trigger rallies.
High volume indicates trader interest for hedges.
Leverage amplifies quick drops effectively.
Bearish Case
Pro-business policies fuel S&P 500 gains, eroding HIBS value.
Daily reset causes compounding decay in sideways markets.
Competition from simpler inverse ETFs draws flows away.
High fees erode returns over time.
Regulatory scrutiny on leveraged products adds caution.
Market Sentiment & Investor Psychology
Short interest limited as ETF, but volume spikes show tactical plays.
Options activity leans calls on S&P, hurting bearish HIBS.
Institutional ownership low at under 10%.
Retail chases momentum, favoring bull ETFs now.
Sentiment skews neutral, with value bias over momentum shorts.
Short-Term Outlook
Technicals point to range-bound action near $4.50.
Momentum from volume supports mild bounce if S&P dips.
Watch Fed comments for volatility spikes.
Expect sideways grind unless broader selloff emerges.
Medium to Long-Term Outlook
Business model suits short hedges, not buy-and-hold.
High beta sector grows with AI/tech, against HIBS thesis.
Financial health solid via Direxion backing.
Risks outweigh as bull market persists.
Long-term investors should watch, not accumulate.
FAQ Section
Is HIBS ETF a buy right now?
No, for most; suits short-term bearish bets only.
What is the price target for HIBS ETF?
Analysts eye $5.20 average amid volatility.
What are major risks for HIBS ETF?
Leverage decay and bull markets top list.
HIBS ETF forecast for 2026?
Bearish bias if equities rally continues.
What drives HIBS ETF price?
Inverse high beta S&P 500 daily moves.
Suggestions
Compare with SOXS ETF analysis
See our S&P 500 forecast
Read our leveraged ETF risks breakdown
Conclusion
Hold for traders, Watchlist for others.
HIBS ETF fits tactical shorts in downturns but struggles in bull markets. Leverage decay limits appeal. Strong S&P momentum favors caution.
Disclaimer: This article is for informational purposes only and not financial advice.